Drug Administration From Enteral Nutrition Tube

March 29, 2023 updated by: Emel Külekçi

The Effect Of The Check List Developed For Drug Administration From Enteral Nutrition Tube On Administration Errors

Enteral nutrition protocols are applied in patients who do not have gastrointestinal dysfunction but in whom oral feeding is contraindicated. In these patients, where drug use is also necessary but alternative drug administration routes are not possible, drugs can be given to the patient through enteral nutrition tubes. However, there are studies reporting errors and complications during drug administration from the enteral nutrition tube. With the planned thesis study, it is aimed to develop an evidence-based checklist and to reduce the rate of errors and complications in drug administration through enteral feeding tube with this checklist.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Enteral nutrition protocols are applied in patients who do not have gastrointestinal dysfunction but in whom oral feeding is contraindicated. In these patients, where drug use is also necessary but alternative drug administration routes are not possible, drugs can be given to the patient through enteral nutrition tubes.

When adding drugs to parenteral nutrition admixtures or using concomitant drugs from the same catheter, it has become a general rule to check for drug incompatibility. The same level of care is not taken in drug administration from the enteral nutrition tube. There are studies reporting errors and complications in enteral drug administration in the literature Today, one of the most important parts of corporate culture in healthcare is patient safety. Patient safety is all of the measures taken by health institutions and employees in these institutions in order to prevent the harm that health care services may cause to individuals. The main goal here is; It is the establishment of a system that will protect the patient from possible harm and eliminate the possibility of error due to errors that will prevent the occurrence of errors during care delivery.

The checklists used in recent years are also an evidence-based practice list and have become one of the effective methods used to prevent errors and reduce complications. A checklist standardizes the process, streamlines maintenance delivery, and improves performance to ensure all actions are covered. The checklist allows cross-checking what was done and in what order. These reassurances are important in situations where time is short and distractions.

With this study, it is aimed to develop an evidence-based checklist and to reduce the rate of errors and complications in drug administration through enteral feeding tube with this checklist.

Study Type

Interventional

Enrollment (Actual)

69

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Keçiören
      • Ankara, Keçiören, Turkey, 06210
        • Sağlık Bilimleri Üniversitesi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Being an intensive care nurse
  • Have experience in administering enteral medication
  • Administering enteral medication to an adult patient
  • Agree to participate in the research

Exclusion Criteria:

  • Administering enteral medication to a patient with fluid restriction
  • Change of position
  • Wanting to leave research

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: no intervention
Experimental: checklist
Other: Checklist
the experimental group will practice using the checklist

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in enteral drug administration error rates of nurses with an interval of 2 months
Time Frame: baseline and month 2

First, the error rates of 69 nurses during enteral drug administration were calculated.

Enteral medication was administered for approximately one month with the next intervention group (n=34) checklist. Finally, the error rates of 69 nurses during enteral drug administration were recalculated.

Error rates were determined with a 19-item observation formula. Name of the form; Medication from Enteral Feeding Tube Observation Form for Applications The lowest error rate is 0%, the highest error rate is 100%.
baseline and month 2

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in enteral drug administration knowledge of nurses with an interval of 2 months
Time Frame: baseline and month 2

First, the knowledge levels of 69 nurses on enteral drug administration were calculated.

Then the intervention group (n=34) administered enteral medication for approximately one month along with the checklist. Finally, the knowledge levels of 69 nurses on enteral drug administration were recalculated.

Knowledge levels were determined with a 20-item information form. Name of the form; It is an Information Evaluation Form for Drug Administrations from Enteral Feeding Tube.

The lowest score is 0, the highest score is 100.
baseline and month 2

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Emel Külekçi

Investigators

  • Principal Investigator: EMEL KÜLEKCİ, PhD student

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 15, 2022

Primary Completion (Actual)

May 15, 2022

Study Completion (Actual)

June 15, 2022

Study Registration Dates

First Submitted

February 16, 2023

First Submitted That Met QC Criteria

March 29, 2023

First Posted (Actual)

March 30, 2023

Study Record Updates

Last Update Posted (Actual)

March 30, 2023

Last Update Submitted That Met QC Criteria

March 29, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2021/29

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intensive Care

Clinical Trials on Checklist

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe